Published in In Vitro Cell Dev Biol Anim on January 01, 2001
Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol (2012) 2.99
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol (2006) 1.72
Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology (2003) 1.46
Corticotropin releasing hormone and the skin. Front Biosci (2006) 1.45
CRH functions as a growth factor/cytokine in the skin. J Cell Physiol (2006) 1.38
Corticotropin-releasing hormone stimulates NF-kappaB in human epidermal keratinocytes. J Endocrinol (2004) 1.10
On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders. Br J Dermatol (2009) 1.02
Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim Pol (2010) 0.97
CRH mediates inflammation induced by lipopolysaccharide in human adult epidermal keratinocytes. J Invest Dermatol (2006) 0.94
Corticotropin-releasing hormone inhibits nuclear factor-kappaB pathway in human HaCaT keratinocytes. J Invest Dermatol (2003) 0.92
Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides. FASEB J (2006) 0.90
Stress-linked cortisol concentrations in hair: what we know and what we need to know. Rev Neurosci (2011) 0.90
Corticotropin-releasing hormone triggers differentiation in HaCaT keratinocytes. Br J Dermatol (2005) 0.90
Neurotensin and CRH interactions augment human mast cell activation. PLoS One (2012) 0.82
Neuroendocrinology of the skin: An overview and selective analysis. Dermatoendocrinol (2011) 0.81
Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors. Br J Pharmacol (2009) 0.79
Urocortin induced expression of COX-2 and ICAM-1 via corticotrophin-releasing factor type 2 receptor in rat aortic endothelial cells. Br J Pharmacol (2009) 0.78
Exploring the Physiological Link between Psoriasis and Mood Disorders. Dermatol Res Pract (2015) 0.75
Does the corticotropin-releasing hormone system play a role in the pathogenesis of lichen planus? Postepy Dermatol Alergol (2017) 0.75
Inhibiting interleukin-18 production through the mitogen-activated protein kinase pathway, a potential role of corticotropin-releasing hormone in chronic plaque psoriasis. Inflammation (2015) 0.75
Neuroendocrinology of the skin. Endocr Rev (2000) 3.34
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab (1987) 2.35
Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol (1991) 2.33
beta-endorphin is a potent analgesic agent. Proc Natl Acad Sci U S A (1976) 2.30
Age, vitamin D, and solar ultraviolet. Lancet (1989) 1.82
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J (2001) 1.74
The effect of standard- and high-dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitation. JAMA (1991) 1.74
Maltreatment of boys and the development of disruptive and delinquent behavior. Dev Psychopathol (2001) 1.70
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med (1993) 1.58
Glycosaminoglycans in histologic sections. Arch Dermatol (1987) 1.39
Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim Biophys Acta (1996) 1.39
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
CRH functions as a growth factor/cytokine in the skin. J Cell Physiol (2006) 1.38
Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. A preliminary study. Arch Dermatol (1988) 1.30
Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Miner Res (1986) 1.27
Asbestos: mechanisms of toxicity and carcinogenicity in the respiratory tract. Annu Rev Pharmacol Toxicol (1983) 1.21
Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest (1993) 1.20
Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab (1992) 1.20
Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci (1999) 1.18
Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured human melanoma cells. FEBS Lett (1999) 1.17
Active steroidogenesis in the normal rat skin. Biochim Biophys Acta (2000) 1.17
A characterization of hypothalamic-pituitary-adrenal axis function during and after human cardiac arrest. Crit Care Med (1993) 1.12
Celiac disease-associated autoimmune endocrinopathies. Clin Diagn Lab Immunol (2001) 1.10
UV light and MSH receptors. Ann N Y Acad Sci (1999) 1.09
Characterization of a novel, potent, and specific inhibitor of serine palmitoyltransferase. J Biol Chem (1992) 1.07
Kinetic and thermodynamic studies of the conversion of previtamin D3 to vitamin D3 in human skin. J Biol Chem (1993) 1.07
Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab (1998) 1.06
Thyrotrophin-releasing hormone and shaking behaviour in rat. Nature (1975) 1.06
What are subcutaneous adipocytes really good for? Exp Dermatol (2007) 1.06
Mast cell involvement in murine hair growth. Dev Biol (1994) 1.06
What's the use of generating melanin? Exp Dermatol (1999) 1.04
Adrenomedullary response to maximal stress in humans. Am J Med (1984) 1.04
Family-based association test method: age of onset traits and covariates. Genet Epidemiol (2001) 1.04
Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cell Dev Biol Anim (2000) 1.04
On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol (1993) 1.04
Malignant melanoma. Arch Pathol Lab Med (2001) 1.04
Compensation for the interracial variance in the cutaneous synthesis of vitamin D. J Lab Clin Med (1995) 1.03
On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders. Br J Dermatol (2009) 1.02
Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int J Oncol (2006) 1.02
Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J Pineal Res (2006) 1.01
The skin produces urocortin. J Clin Endocrinol Metab (2000) 1.01
Airborne mutagens bioassayed in Salmonella typhimurium. J Natl Cancer Inst (1977) 1.01
Modification of melanogenesis in cultured human melanoma cells. In Vitro Cell Dev Biol Anim (2000) 1.00
Quantitative aspects of precipitated abstinence in morphine-dependent rats. J Pharmacol Exp Ther (1973) 1.00
Central cardiovascular effects of enkephalins and C-fragment of lipotropin [proceedings]. J Physiol (1978) 0.99
Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. FASEB J (1998) 0.99
Steroidogenesis in the human skin: 21-hydroxylation in cultured keratinocytes. J Steroid Biochem Mol Biol (2001) 0.99
Molecular pathology of soft tissue and bone tumors. A review. Arch Pathol Lab Med (1999) 0.98
Endorphins may function in heat adaptation. Proc Natl Acad Sci U S A (1978) 0.98
Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs. Anticancer Res (2001) 0.98
In vivo threshold for cutaneous synthesis of vitamin D3. J Lab Clin Med (1989) 0.98
Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med (1995) 0.97
Adrenal insufficiency in high-risk surgical ICU patients. Chest (2001) 0.97
Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Lett (1998) 0.97
Brain sites of precipitated abstinence in morphine-dependent rats. J Pharmacol Exp Ther (1973) 0.97
Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin. J Clin Endocrinol Metab (2000) 0.96
Use of topical sunscreen for the evaluation of regional synthesis of vitamin D3. J Am Acad Dermatol (1990) 0.95
Skin histoculture assay for studying the hair cycle. In Vitro Cell Dev Biol (1993) 0.95
Plasma catecholamine and serum cortisol responses to experimental cardiac arrest in dogs. Am J Physiol (1987) 0.94
Spatiotemporal expression, distribution, and processing of POMC and POMC-derived peptides in murine skin. J Histochem Cytochem (2000) 0.93
Central sites at which morphine acts when producing cardiovascular effects [proceedings]. J Physiol (1978) 0.93
The measurement of intestinal calcium absorption by external radioisotope counting: application to study of nephrolithiasis. Clin Sci (1970) 0.93
Ultrasound detection and identification of cosmetic fillers in the skin. J Eur Acad Dermatol Venereol (2011) 0.93
Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin. J Invest Dermatol (1997) 0.93
Alkaline phosphatase (EC 3.1.3.1) in serum is inhibited by physiological concentrations of inorganic phosphate. J Clin Endocrinol Metab (1998) 0.93
Influence of dietary factors on the gastrointestinal absorption of lead. Toxicol Appl Pharmacol (1974) 0.92
Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes. J Pineal Res (2007) 0.92
Physical dependence of opiate-like peptides. Science (1976) 0.92
Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome. J Reprod Med (1994) 0.92
The fate of hair follicle melanocytes during the hair growth cycle. J Investig Dermatol Symp Proc (1999) 0.91
Corticotropin-releasing hormone triggers differentiation in HaCaT keratinocytes. Br J Dermatol (2005) 0.90
Inclusion of satellites in an 18/21 translocation chromosome shown by ammonical-silver staining (sat-banding) in case of partial trisomy 18. J Med Genet (1976) 0.90
Identification and characterization of two isozymic forms of arylamine N-acetyltransferase in Syrian hamster skin. J Invest Dermatol (1993) 0.90
Plasma chromogranin A as a marker of sympathochromaffin activity in humans. Am J Physiol (1991) 0.89
Ultraviolet B and melanocyte-stimulating hormone (MSH) stimulate mRNA production for alpha MSH receptors and proopiomelanocortin-derived peptides in mouse melanoma cells and transformed keratinocytes. J Invest Dermatol (1995) 0.89
[Genetic factors and effect of BCG vaccination in the Mitsuda reaction]. Rev Paul Med (1967) 0.88
Sex steroid levels during treatment of endometriosis. Obstet Gynecol (1979) 0.88
Neuroanatomical correlates of morphine dependence. Science (1972) 0.88
Sonography in pathologies of scalp and hair. Br J Radiol (2012) 0.88
Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. J Clin Endocrinol Metab (1985) 0.88
Cutaneous immunomodulation and coordination of skin stress responses by alpha-melanocyte-stimulating hormone. Ann N Y Acad Sci (1998) 0.88
Spinal meningeal AVM supplied from the internal iliac artery associated with tethered cord syndrome in an adult: case report. J Can Assoc Radiol (1983) 0.87
Methylation pattern at the KvDMR in a child with Beckwith-Wiedemann syndrome conceived by ICSI. Am J Med Genet A (2007) 0.87
Choriocarcinoma presenting as a cutaneous metastasis. J Cutan Pathol (1995) 0.87
Melanotropic activity of gamma MSH peptides in melanoma cells. Life Sci (1992) 0.87
Ocular toxicity of paraquat. Bull Environ Contam Toxicol (1973) 0.87
Spectrum of endocrine abnormalities associated with acanthosis nigricans. Am J Med (1987) 0.86
Regional sensitivity of the rat brain to the inhibitory effects of morphine on wet shake behavior. J Pharmacol Exp Ther (1975) 0.86
The proopiomelanocortin system in cutaneous neuroimmunomodulation. An introductory overview. Ann N Y Acad Sci (1999) 0.86